Showing results (1721-1730 of 2,011) with videos related to
Sort By:
Pageof 202
Biorxiv : the Preprint Server for Biology|July 3, 2023
Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domainSupeshala Nawarathnage, Yi Jie Tseng, Sara Soleimani, et al.Poultry Science|September 20, 2022
Host response to successive challenges with lentogenic and velogenic Newcastle disease virus in local chickens of GhanaP K Botchway, E N Amuzu-Aweh, A Naazie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancerFred R Hirsch, Fairooz Kabbinavar, Tim Eisen, et al.The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.Plos One|May 3, 2014
Emerging infectious diseases in free-ranging wildlife-Australian zoo based wildlife hospitals contribute to national surveillanceKeren Cox-Witton, Andrea Reiss, Rupert Woods, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 21, 2018
Patterns of Single and Multiple Tobacco Product Use Among US Women of Reproductive AgeAllison N Kurti, Janice Y Bunn, Andrea C Villanti, et al.Drug and Alcohol Dependence|February 19, 2019
Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine contentCecilia L Bergeria, Sarah H Heil, Danielle R Davis, et al.Cancer Research|March 17, 2006
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohortSteven A Belinsky, Kieu C Liechty, Frederick D Gentry, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2014
Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infectionPatrick T Bunn, Amanda C Stanley, Fabian de Labastida Rivera, et al.Cancer|February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancerLuis Paz-Ares, David R Spigel, Yuanbin Chen, et al.Pageof 202